Agent’s Information means, solely, the following information in the Prospectus: the third sentence of the eighth paragraph and the tenth paragraph under the caption “Plan of Distribution” in the Prospectus. This indemnity agreement will be in addition to any liability that the Company might otherwise have.
Agent’s Information means, solely the following information in the Prospectus: the eighth and tenth paragraphs under the caption “Plan of Distribution” in the Prospectus. If the foregoing correctly sets forth the understanding between the Company and Cowen, please so indicate in the space provided below for that purpose, whereupon this letter shall constitute a binding agreement between the Company and Cowen. Very truly yours, XXXXX AND COMPANY, LLC By: /s/ Xxxxxx Xxxx Name: Xxxxxx Xxxx Title: Managing Director ACCEPTED as of the date first-above written: SYNLOGIC, INC. By: /s/ Xxxx Xxxxxx Name: Xxxx Xxxxxx Title: Chief Financial Officer SCHEDULE 1 FORM OF PLACEMENT NOTICE From: [ ] Cc: [ ] To: [ ] Subject: Cowen at the Market Offering—Placement Notice Gentlemen: Pursuant to the terms and subject to the conditions contained in the Sales Agreement between Synlogic, Inc., a Delaware corporation (the “Company”), and Xxxxx and Company, LLC (“Cowen”) dated October 13, 2017 (the “Agreement”), I hereby request on behalf of the Company that Cowen sell up to [ ] shares of the Company’s common stock, par value $0.001 per share, at a minimum market price of $[ ] per share. Sales should begin on the date of this Notice and shall continue until [DATE] [all shares are sold]/[the aggregate sales price of the shares reaches $[ ]]. SCHEDULE 2 Synlogic, Inc. The Company’s Chief Executive Officer, who as of the date hereof is XX Xxxxxxxxx-Xxxxx. The Company’s Chief Financial Officer, who as of the date hereof is Xxxx Xxxxxx. Xxxxx and Company, LLC Xxxx Xxxxxx Xxxxxx Xxxx SCHEDULE 3 Compensation Cowen shall be paid compensation equal to 3.0% of the gross proceeds from the sales of Common Stock pursuant to the terms of this Agreement. SCHEDULE 4 Schedule Of Subsidiaries Synlogic Operating Company, Inc. Synlogic IBDCo, Inc. Exhibit 7(m) OFFICER CERTIFICATE The undersigned, the duly qualified and elected , of Synlogic, Inc. (“Company”), a Delaware corporation, does hereby certify in such capacity and on behalf of the Company, pursuant to Section 7(m) of the Sales Agreement dated October [ ], 2017 (the “Sales Agreement”) between the Company and Xxxxx and Company, LLC, that to the best of the knowledge of the undersigned.
Agent’s Information means solely the following information in the Registration Statement and the Prospectus: the ninth paragraph under the heading “Plan of Distribution” in the Prospectus. All references in this Agreement to the Registration Statement, the Prospectus or any amendment or supplement to any of the foregoing shall be deemed to include the copy filed with the Commission pursuant to XXXXX. All references in this Agreement to financial statements and schedules and other information that is “contained,” “included” or “stated” in the Registration Statement or the Prospectus (and all other references of like import) shall be deemed to mean and include all such financial statements and schedules and other information that is incorporated by reference in the Registration Statement or the Prospectus, as the case may be. All references in this Agreement to “supplements” to the Prospectus shall include any supplements, “wrappers” or similar materials prepared in connection with any offering, sale or private placement of any Placement Shares by the Agent outside of the United States. If the foregoing correctly sets forth the understanding between the Company and the Agent, please so indicate in the space provided below for that purpose, whereupon this letter shall constitute a binding agreement between the Company and the Agent. Very truly yours, XXXXXXXXXXX, INC. By: /s/ Xxxx Xxxxx Name: Xxxx Xxxxx Title: President and Chief Executive Officer ACCEPTED as of the date first-above written: LEERINK PARTNERS LLC By: /s/ Xxxxx X. Xxx Name: Xxxxx X. Xxx Title: Head of Alternative Equities SCHEDULE 1 FORM OF PLACEMENT NOTICE From: [ ] [TITLE] XXXXXXXXXXX, INC. Cc: [ ] To: Leerink Partners LLC Subject: Leerink Partners —At the Market Offering—Placement Notice Ladies and Gentlemen: Pursuant to the terms and subject to the conditions contained in the Amended and Restated Sales Agreement, dated February 28, 2024 (the “Agreement”), by and between Schrödinger, Inc., a Delaware corporation (the “Company”), and Leerink Partners LLC (“Leerink Partners”), I hereby request on behalf of the Company that Leerink Partners sell up to $[ ] of shares of common stock, $0.01 par value per share, of the Company (the “Shares”), at a minimum market price of $[ ] per share[; provided that no more than [ ] Shares shall be sold in any one Trading Day (as such term is defined in Section 3 of the Agreement)]. Sales should begin [on the date of this Placement Notice] and end on [DATE] [until all Shares that a...
Examples of Agent’s Information in a sentence
Neither the Prospectus nor any amendment or supplement thereto, as of its date and as of each Representation Date, included, includes or will include an untrue statement of a material fact or omitted, omits or will omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading, except that the representations and warranties set forth in this sentence do not apply to the Agent’s Information (as defined herein).
As used in this Agreement, Agent’s Information means, solely the following information in the Prospectus: the last sentence in the ninth paragraph under the caption “Plan of Distribution” in the Prospectus.
The representations and warranties set forth in the two immediately preceding sentences do not apply to statements in or omissions from the Registration Statement, any Rule 462(b) Registration Statement, or any post-effective amendment thereto, or the Prospectus, or any amendments or supplements thereto, made in reliance upon and in conformity with information relating to Agent’s Information (as defined below).
More Definitions of Agent’s Information
Agent’s Information means, solely the following information in the Prospectus: the third sentence of the eighth paragraph under the caption “Plan of Distribution” in the Prospectus.
Agent’s Information means solely the following information in the Registration Statement and the Prospectus: the ninth paragraph under the heading “Plan of Distribution” in the Prospectus Supplement. All references in this Agreement to the Registration Statement, the Prospectus or any amendment or supplement to any of the foregoing shall be deemed to include the copy filed with the Commission pursuant to XXXXX. All references in this Agreement to financial statements and schedules and other information that is “contained,” “included” or “stated” in the Registration Statement or the Prospectus (and all other references of like import) shall be deemed to mean and include all such financial statements and schedules and other information that is incorporated by reference in the Registration Statement or the Prospectus, as the case may be. All references in this Agreement to “supplements” to the Prospectus shall include any supplements, “wrappers” or similar materials prepared in connection with any offering, sale or private placement of any Placement Shares by the Agent outside of the United States. If the foregoing correctly sets forth the understanding between the Company and the Agent, please so indicate in the space provided below for that purpose, whereupon this letter shall constitute a binding agreement between the Company and the Agent. Very truly yours, KEROS THERAPEUTICS, INC. By: /s/ Xxxxxx Xxxxxx Name: Xxxxxx Xxxxxx Title: Chief Executive Officer ACCEPTED as of the date first-above written: SVB LEERINK LLC By: /s/ Xxxxx X. Xxx Name: Xxxxx X. Xxx Title: Head of Alternative Equities SCHEDULE 1 FORM OF PLACEMENT NOTICE From: [ ] [TITLE] Keros Therapeutics, Inc. Cc: [ ] To: SVB Leerink LLC Subject: SVB Leerink—At the Market Offering—Placement Notice Ladies and Gentlemen: Pursuant to the terms and subject to the conditions contained in the Sales Agreement, dated May 3, 2021 (the “Agreement”), by and between Keros Therapeutics, Inc., a Delaware corporation (the “Company”), and SVB Leerink LLC (“SVB Leerink”), I hereby request on behalf of the Company that SVB Leerink sell up to [ ] shares of common stock, $0.0001 par value per share, of the Company (the “Shares”), at a minimum market price of $ per share[; provided that no more than [ ] Shares shall be sold in any one Trading Day (as such term is defined in Section 3 of the Agreement)]. Sales should begin [on the date of this Placement Notice] and end on [DATE] [until all Shares that are the subject of this Placement Notice...
Agent’s Information means, solely the following information in the Prospectus: the eighth and tenth paragraphs under the caption “Plan of Distribution” in the Prospectus.
Agent’s Information means, solely the following information in the Prospectus: the sixth paragraph and the second sentence in the seventh paragraph under the caption “Plan of Distribution” in the Prospectus. If the foregoing correctly sets forth the understanding between the Company and Cowen, please so indicate in the space provided below for that purpose, whereupon this letter shall constitute a binding agreement between the Company and Cowen. Very truly yours, XXXXX AND COMPANY, LLC By: /s/ Xxxxxxx Xxxxxx Name: Xxxxxxx Xxxxxx Title: Managing Director ACCEPTED as of the date first-above written: SERES THERAPEUTICS, INC. By: /s/ Xxxx X. Xxxxx Name: Xxxx X. Xxxxx Title: President and Chief Executive Officer SCHEDULE 1 FORM OF PLACEMENT NOTICE From: [ ] Cc: [ ] To: [ ] Subject: Cowen at the Market Offering—Placement Notice Gentlemen: Pursuant to the terms and subject to the conditions contained in the Sales Agreement between Seres Therapeutics, Inc. (the “Company”), and Xxxxx and Company, LLC (“Cowen”) dated May 21, 2021 (the “Agreement”), I hereby request on behalf of the Company that Cowen sell up to [ ] shares of the Company’s common stock, par value $0.001 per share, at a minimum market price of $ per share. Sales should begin on the date of this Notice and shall continue until [DATE] [all shares are sold]. SCHEDULE 2 Seres Therapeutics, Inc. Xxxx X. Xxxxx – Chief Executive Officer Xxxxx and Company, LLC Xxxxxxx X. Xxxxxx – Managing Director Xxxxxxx Xxxxxx – Managing Director SCHEDULE 3 Compensation Cowen shall be paid compensation up to 3.0% of the gross proceeds from the sales of Common Stock pursuant to the terms of this Agreement. Exhibit 7(m) OFFICER CERTIFICATE The undersigned, the duly qualified and elected , of Seres Therapeutics, Inc. (“Company”), a Delaware corporation, does hereby certify in such capacity and on behalf of the Company, pursuant to Section 7(m) of the Sales Agreement dated May 21, 2021 (the “Sales Agreement”) between the Company and Xxxxx and Company, LLC, that to the best of the knowledge of the undersigned.
Agent’s Information means, solely the following information in the Prospectus: the information under the caption “Plan of Distribution” in the Prospectus Supplement. If the foregoing correctly sets forth the understanding between the Company and Cowen, please so indicate in the space provided below for that purpose, whereupon this letter shall constitute a binding agreement between the Company and Cowen. Very truly yours, XXXXX AND COMPANY, LLC By: /s/ Xxxxx Xxxxxx Name: Xxxxx Xxxxxx Title: Manager ACCEPTED as of the date first-above written: PIERIS PHARMACEUTICALS, INC. By: /s/ Xxxxxxx Xxxxxxx-Xxxxx Name: Xxxxxxx Xxxxxxx-Xxxxx Title: SVP & Chief Financial Officer SCHEDULE 1 FORM OF PLACEMENT NOTICE From: Pieris Pharmaceuticals, Inc. To: Xxxxx and Company, LLC Subject: Cowen at the Market Offering—Placement Notice Gentlemen: Pursuant to the terms and subject to the conditions contained in the Sales Agreement between Pieris Pharmaceuticals, Inc., a Nevada corporation (the “Company”), and Xxxxx and Company, LLC (“Cowen”) dated October 5, 2016 (the “Agreement”), I hereby request on behalf of the Company that Cowen sell up to [●] shares of the Company’s common stock, par value $0.001 per share, at a minimum market price of $[●] per share. Sales should begin on the date of this Notice and shall continue until [DATE] [all shares are sold] [the aggregate sales price of the shares reaches $[●]. The Company may include such other sales parameters as it deems appropriate in its sole discretion. SCHEDULE 2
Agent’s Information means solely the following information in the Registration Statement and the Prospectus: the last sentence of the eighth paragraph and the ninth paragraph under the heading “Plan of Distribution” in the Prospectus Supplement.
Agent’s Information means, solely the following information in the Prospectus: the fifth (5th) paragraph under the caption “Plan of Distribution” in the Prospectus Supplement. All references in this Agreement to the “knowledge of the Company” or the “Company’s knowledge” or similar qualifiers shall mean the actual knowledge of Xxxxxxx Xxxxxxx, Xxxxxxxxx Xxxxx, Xxxxxxxx Xxxxx, Xxxx Xxxx and Xxxxxx Kelenkofske, after due inquiry. All references in this Agreement to financial statements and schedules and other information that is “contained,” “included” or “stated” in the Registration Statement or the Prospectus (and all other references of like import) shall be deemed to mean and include all such financial statements and schedules and other information that is incorporated by reference in the Registration Statement or the Prospectus, as the case may be. All references in this Agreement to “supplements” to the Prospectus shall include, without limitation, any supplements, “wrappers” or similar materials prepared in connection with any offering, sale or private placement of any Placement Shares by Leerink outside of the United States. 42 If the foregoing correctly sets forth the understanding between the Company and Leerink, please so indicate in the space provided below for that purpose, whereupon this letter shall constitute a binding agreement between the Company and Leerink. Very truly yours, UNIQURE N.V. By: /s/ Xxxx Xxxxxxx Name: Xxxx Xxxxxxx Title: Chief Executive Officer By: /s/ Xxxxxx Gut Name: Xxxxxx Gut Title: Chief Medical Officer ACCEPTED as of the date first-above written: SVB LEERINK LLC By: /s/ Xxxxxx Xxxxx Name: Xxxxxx Xxxxx Title: Vice Chairman SCHEDULE 1 FORM OF PLACEMENT NOTICE From: [ ] Cc: [ ] To: [ ] Subject: SVB Leerink LLC—At The Market Offering—Placement Notice Gentlemen: Pursuant to the terms and subject to the conditions contained in the Sales Agreement, dated March [●], 2020 (the “Agreement”), by and between uniQure N.V., a Dutch public company with limited liability (the “Company”), and SVB Leerink LLC (“Leerink”), I hereby request on behalf of the Company that Leerink sell up to [ ] ordinary shares, nominal value €0.05 per share, of the Company (the “Ordinary Shares”), at a minimum market price of $ per share[, provided that no more than [ ] Ordinary Shares shall be sold in any one Trading Day, as such term is defined in Section 3 of the Agreement]. Sales should begin on the date of this Notice and shall continue until [DATE] [all such shares are so...